๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Molecular mechanisms in the pathogenesis of cirrhotic portal hypertension: focus on nitric oxide

โœ Scribed by VIJAY SHAH


Book ID
108950089
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
93 KB
Volume
19
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The cellular pathogenesis of portal hype
โœ Don Rockey ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 277 KB

HEPATOLOGY Concise Review sion. 1 Their precise site of action is controversial but in The Cellular Pathogenesis of theory could be at any of several levels within the liver, including presinusoidal, sinusoidal, or postsinusoidal. [2][3][4] Portal Hypertension: Stellate A recent development in the f

Effects of nitric oxide and cyclooxygena
โœ Yuping Wu; R. Cartland Burns; James V. Sitzmann ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 563 KB

Portal hypertension is associated with splanchnic hyperemia and increased plasma levels of prostacyclin. Recently, nitric oxide was proposed as a mediator of this arterial vasodilatation. We hypothesized that portal hypertension alters the relative contribution of prostacyclin and nitric oxide to sp

Effects of vasopressin on portal-systemi
โœ Che-Chang Chan; Fa-Yauh Lee; Sun-Sang Wang; Full-Young Chang; Han-Chieh Lin; Chi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB

This study investigated the effect of vasopressin on portal-systemic collaterals in portal hypertensive rats and the influence of nitric oxide (NO) and prostaglandin on the responsiveness of collateral vessels to vasopressin. The vascular responsiveness to graded concentrations of vasopressin was te

The role of nitric oxide in the vascular
โœ Fa-Yauh Lee; Agustin Albillos; Luis A. Colombato; Roberto J. Groszmann ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 607 KB

This study examined whether an increased activity of the endothelium-derived relaxing factor, nitric oxide, may account for the hyporesponsiveness to vasoconstrictors in portal hypertension. W e performed dose-response curves to methoxamine, an eadrenoceptor agonist, with and without N"dtr0-Larginin